ALPS Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $157K | Sell |
36,910
-13,574
| -27% | -$57.8K | ﹤0.01% | 1016 |
|
2025
Q1 | $190K | Buy |
50,484
+4,149
| +9% | +$15.6K | ﹤0.01% | 964 |
|
2024
Q4 | $270K | Buy |
46,335
+644
| +1% | +$3.76K | ﹤0.01% | 949 |
|
2024
Q3 | $546K | Buy |
45,691
+2,039
| +5% | +$24.3K | ﹤0.01% | 594 |
|
2024
Q2 | $472K | Buy |
43,652
+4,791
| +12% | +$51.8K | ﹤0.01% | 589 |
|
2024
Q1 | $440K | Buy |
38,861
+698
| +2% | +$7.9K | ﹤0.01% | 611 |
|
2023
Q4 | $535K | Buy |
+38,163
| New | +$535K | ﹤0.01% | 594 |
|